Gallium 68 PSMA-11 (Ga 68 PSMA-11)is the First PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer
3 Dicembre 2020
U.S. Food and Drug Administration has approved Gallium 68 PSMA-11 (Ga 68 PSMA-11) – the first drug for positron emission tomography (PET) imaging of prostate-specific
